Standard Biotools (LAB) Total Debt (QoQ) (2011 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.24% |
| Dec 31, 2023 | 502.64% |
| Sep 30, 2023 | -7.48% |
| Jun 30, 2023 | 0.56% |
| Mar 31, 2023 | 26.12% |
| Dec 31, 2022 | -12.70% |
| Sep 30, 2022 | -7.64% |
| Jun 30, 2022 | 0.55% |
| Mar 31, 2022 | -40.16% |
| Dec 31, 2021 | 68.99% |
| Sep 30, 2012 | -33.70% |
| Jun 30, 2012 | -55.42% |
| Mar 31, 2012 | -37.43% |
| Dec 31, 2011 | -12.53% |
| Sep 30, 2011 | 146.81% |
| Jun 30, 2011 | 67.71% |
| Mar 31, 2011 | -80.95% |